Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3840619 | 0.90 | MEN1 (0.32) | MEN1ALDH1A1KMT2A | |
| SCHEMBL3849628 | 0.89 | — | — | |
| SCHEMBL3845442 | 0.88 | — | — | |
| SCHEMBL1056015 | 0.87 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL2343747 | 0.87 | EPHX2 (0.36) | MEN1ALDH1A1KMT2AEPHX2 | |
| SCHEMBL3845910 | 0.82 | EPHX2 (0.30) | EPHX2 | |
| SCHEMBL22494383 | 0.82 | MEN1 (0.37) | MEN1ALDH1A1KMT2A | |
| SCHEMBL3845885 | 0.80 | — | — | |
| SCHEMBL4805947 | 0.78 | MEN1 (0.30) | MEN1ALDH1A1KMT2A | |
| SCHEMBL3841069 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2216336-B1 | PROCESS FOR PRODUCTION OF CYCLIC POLYORGANOSILOXANE, CURING AGENT, CURABLE COMPOSITION, AND CURED PRODUCT OF THE CURABLE COMPOSITION | KANEKA CORP (JP) | 2015-11-04 | — | — | EP | claimed |
| EP-1967540-B1 | CURABLE COMPOSITION | KANEKA CORP (JP) | 2013-04-03 | — | — | EP | claimed |
| US-8273842-B2 | Process for production of cyclic polyorganosiloxane, curing agent, curable composition, and cured product of the curable composition | KANEKA CORPORATION (JP) | 2012-09-25 | — | — | US | claimed |
| US-8263725-B2 | Curable composition | KANEKA CORPORATION (JP) | 2012-09-11 | — | — | US | claimed |
| US-20100267919-A1 | PROCESS FOR PRODUCTION OF CYCLIC POLYORGANOSILOXANE, CURING AGENT, CURABLE COMPOSITION, AND CURED PRODUCT OF THE CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2010-10-21 | — | — | US | claimed |
| US-20100222525-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2010-09-02 | — | — | US | claimed |
| EP-2216336-A1 | PROCESS FOR PRODUCTION OF CYCLIC POLYORGANOSILOXANE, CURING AGENT, CURABLE COMPOSITION, AND CURED PRODUCT OF THE CURABLE COMPOSITION | Kaneka Corporation (JP) | 2010-08-11 | — | — | EP | claimed |
| EP-1967540-A1 | CURABLE COMPOSITION | Kaneka Corporation (JP) | 2008-09-10 | — | — | EP | claimed |
| US-20260020362-A1 | RIBBED SUBSTRATE AND OPTICAL SEMICONDUCTOR DEVICE | KANEKA CORP (JP) | 2026-01-15 | — | — | US | disclosed |
| US-20250066595-A1 | CURABLE RESIN COMPOSITION | THREEBOND CO., LTD. (JP) | 2025-02-27 | — | — | US | disclosed |
| US-20250015105-A1 | SUBSTRATE LAMINATE, IMAGE SENSOR, AND METHOD FOR MANUFACTURING SUSTRATE LAMINATE | KANEKA CORPORATION (JP) | 2025-01-09 | — | — | US | disclosed |
| EP-4455225-A1 | CURABLE RESIN COMPOSITION | ThreeBond Co., Ltd. (JP) | 2024-10-30 | — | — | EP | disclosed |
| CN-118434809-A | Curable resin composition | 三键有限公司 | 2024-08-02 | — | — | CN | disclosed |
| US-20240206322-A1 | OPTICAL SEMICONDUCTOR DEVICE, METHOD FOR MANUFACTURING SAME, SOLID-STATE IMAGING DEVICE, AND ELECTRONIC DEVICE | KANEKA CORPORATION (JP) | 2024-06-20 | — | — | US | disclosed |
| US-7754903-B2 | adamantyl diglycidyl ether or 1-adamantanol epichlorohydrin adduct curable to polyepoxides; encapsulant for light-emitting diode; superior optical properties, heat resistance, photostability, and shrinkage inhibition | TOKUYAMA CORPORATION (JP) | 2010-07-13 | — | — | US | disclosed |
| JP-2008239579-A | METHOD OF PRODUCING EPOXY COMPOUND | TOKUYAMA CORP | 2008-10-09 | — | — | JP | disclosed |
| EP-1967540-A1 | CURABLE COMPOSITION | Kaneka Corporation (JP) | 2008-09-10 | — | — | EP | disclosed |
| JP-2007308397-A | SILICON-CONTAINING ADAMANTANE COMPOUND | TOKUYAMA CORP | 2007-11-29 | — | — | JP | disclosed |
| US-20060252911-A1 | adamantyl diglycidyl ether or 1-adamantanol epichlorohydrin adduct curable to polyepoxides; encapsulant for light-emitting diode; superior optical properties, heat resistance, photostability, and shrinkage inhibition | TOKYUYAMA CORPORATION (JP) | 2006-11-09 | — | — | US | disclosed |
| EP-1637526-A1 | CURABLE POLYCYCLIC COMPOUNDS AND PROCESS FOR THE PRODUCTION THEREOF | TOKUYAMA CORPORATION (JP) | 2006-03-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260020362-A1 | RIBBED SUBSTRATE AND OPTICAL SEMICONDUCTOR DEVICE | SOST, CASK, STRADA | MEN1 4264/4885ALDH1A1 477/4885KMT2A 4505/4885 |
| US-20100267919-A1 | PROCESS FOR PRODUCTION OF CYCLIC POLYORGANOSILOXANE, CURING AGENT, CURABLE COMPOSITION, AND CURED PRODUCT OF THE CURABLE COMPOSITION | SMCHD1, SQLE, SMARCA5 | MEN1 2819/4885ALDH1A1 1525/4885KMT2A 2334/4885 |
| US-20060252911-A1 | adamantyl diglycidyl ether or 1-adamantanol epichlorohydrin adduct curable to polyepoxides; encapsulant for light-emitting diode; superior optical properties, heat resistance, photostability, and shrinkage inhibition | PFN1, FSCN1, PFDN1 | MEN1 1965/4885ALDH1A1 50/4885KMT2A 1673/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.